Skip to main content

Prostate mpMRI - the scan before the biopsy.

A 30–40 minute 3T MRI using T2, diffusion and dynamic contrast sequences. Reported to PI-RADS v2.1 by a UK uroradiologist. Since NICE NG131, mpMRI has been the first investigation for raised PSA - before a biopsy is even considered.

A radiographer guides a patient onto the bed of an advanced 3 Tesla MRI scanner in a London imaging suite

Indicative pricing

What a private prostate mpMRI costs in the UK.

Indicative ranges across UK imaging units.

In short

£600–£1,200, report in 5–7 working days.

Procedure Indicative range
Prostate mpMRI (3T with contrast) £600–£1,200
Prostate mpMRI (1.5T) £500–£900
MRI-targeted transperineal biopsy £3,500–£6,500
MRI-fusion transrectal biopsy £3,000–£5,500
Urology consultation £250–£450
PSA + free/total PSA £80–£180

Prices vary by scanner (3T is preferred), by uroradiologist and by whether MRI-targeted biopsy is bundled.

The problem

NICE says MRI first - but not everywhere delivers that pathway well.

NICE NG131 (updated) recommends mpMRI before a prostate biopsy where there is suspected localised prostate cancer. Done well, it avoids around a quarter of biopsies and finds more clinically significant cancers. Done badly, it does the opposite.

  • PI-RADS 1–2 usually skips biopsy

    With supportive clinical picture, low PI-RADS spares many men a biopsy.

  • PI-RADS 3 needs judgement

    Intermediate scores need clinical context and, often, MRI-targeted biopsy.

  • PI-RADS 4–5 needs biopsy

    These deserve an MRI-fusion targeted biopsy at a high-volume centre.

When it helps

When a prostate mpMRI is the right step.

Situations where mpMRI is now the standard first investigation.

  • Raised PSA on screening or investigation

    Age-adjusted PSA above threshold - MRI before biopsy per NICE NG131.

  • Abnormal DRE

    A palpable nodule - MRI adds detail before biopsy.

  • Family history or BRCA2

    Higher-risk men often start MRI-first pathways earlier.

  • Rising PSA on active surveillance

    Trigger to re-image and possibly re-biopsy.

  • Post-radiotherapy biochemical recurrence

    MRI localises local recurrence before salvage.

  • Prior negative biopsy with persistent suspicion

    Better characterisation than repeat systematic biopsy.

  • Focal therapy planning

    HIFU or cryotherapy planning needs a detailed MRI map.

  • Red flag: bone pain or weight loss

    These change the picture - needs urgent oncology, not a routine MRI booking.

Procedure options

Options within prostate MRI.

Scanner strength, contrast and biopsy planning.

  • 3T mpMRI (preferred)

    Better diffusion resolution - the modern standard.

  • 1.5T mpMRI

    Acceptable with excellent technique; often more comfortable in wide-bore scanners.

  • Bi-parametric MRI

    T2 + DWI only, no contrast. Sometimes used for screening; not standard for clinical work.

  • PI-RADS v2.1

    Structured 1–5 score per lesion - internationally agreed reporting.

  • MRI-fusion biopsy

    Targets PI-RADS lesions using stored MRI plus live ultrasound.

  • Transperineal vs transrectal biopsy

    Transperineal has a lower infection risk and is increasingly the UK standard.

  • Repeat MRI on active surveillance

    Annual or biennial re-scanning to detect progression.

  • Post-radiotherapy MRI

    Different appearance - needs a reader used to treated glands.

Safety and recovery

What to expect afterwards - honestly.

The safety profile is well understood. What matters is choosing the right test, and reading the report honestly.

  • No radiation

    MRI uses magnetic fields - safe to repeat.

  • Contrast reactions rare

    Modern gadolinium has a very low reaction rate. Kidney function checked in at-risk patients.

  • Buscopan considerations

    Anti-spasmodic used to reduce bowel motion - not for glaucoma or severe cardiac disease.

  • Claustrophobia

    Wide-bore scanners and sedation help; the scan is 30–40 minutes.

  • Metal implants and pacemakers

    Older devices may exclude MRI - questionnaire before booking.

  • PI-RADS 3 is a grey zone

    Discussion at MDT; not every PI-RADS 3 needs a biopsy.

  • Not a screening scan alone

    mpMRI complements PSA and clinical judgement; it doesn’t replace them.

  • When to escalate

    Retention, bone pain or spinal symptoms - same-day urology or A&E, not a routine MRI.

Reading your operation note

Your operation note in four parts. Read the last one first.

Whichever centre does the scan, the report keeps to the same shape.

A UK consultant reviewing operation notes

A quiet reminder

Surgical language is precise and can read coldly - it is fine to ask for plain English.

It is reasonable to ask your clinician to talk you through the operation note and any histology before your review.

  1. 01 Header

    Indication and protocol

    PSA, prior imaging, scanner strength and sequences.

  2. 02 Findings

    Zonal anatomy and lesions

    Peripheral, transition and central zones; each lesion sized and located by sector.

  3. 03 PI-RADS

    Score per lesion

    1–5 score with confidence and biopsy recommendation.

  4. 04 Impression

    Summary and next step

    Read this first - overall PI-RADS, index lesion location and MDT/biopsy recommendation.

Recognised by major UK insurers

BupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealixBupaAXA HealthVitalityAvivaWPACignaHealix

Imaging is usually covered by UK private medical insurance when there’s a specialist referral and a clear clinical indication. Screening scans in well people are almost always self-pay.

Frequently asked

Common questions about prostate mpmri.

Quick answers on approach, recovery, risks and cost.

  • Why do I need an MRI before a prostate biopsy?

    NICE NG131 recommends mpMRI before biopsy because it avoids around a quarter of biopsies and finds more clinically significant cancers than a systematic biopsy alone.

  • What is PI-RADS?

    Prostate Imaging Reporting and Data System - a 1–5 score per lesion indicating the likelihood of clinically significant cancer. 1 and 2 usually skip biopsy; 3 needs judgement; 4 and 5 warrant a targeted biopsy.

  • How much does a private prostate mpMRI cost in the UK?

    £600–£1,200 at 3T with contrast; £500–£900 at 1.5T. MRI-targeted biopsy at a high-volume centre is £3,000–£6,500 depending on approach.

  • Is my insurer likely to cover it?

    Usually yes for a raised PSA or clinical suspicion, with a urology referral. Screening MRI in a well man is typically self-pay.

  • Do I need contrast for the MRI?

    Multi-parametric MRI (T2 + DWI + dynamic contrast) is the standard; bi-parametric MRI without contrast is sometimes used for screening but is not the recommended clinical workup.

  • What happens after PI-RADS 4 or 5?

    An MRI-fusion targeted biopsy at a high-volume centre, ideally transperineal to lower infection risk.

Related treatments

Looking for something else?